76 filings
Page 3 of 4
8-K
51cdxfe
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
fiwbjx54f7jndcj2feyd
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
hed21gd
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
oyz1k4gxx7jr700gog6m
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
9bsr08qmewh3
13 Apr 21
Other Events
4:06pm
8-K
wwyx5gw ty4htsm3
31 Mar 21
Other Events
4:05pm
8-K
zbz5pel4 vd
30 Mar 21
Other Events
6:07am
8-K
h23xk77ir vb
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
83izmbfnr2946dk
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
mpt364hiht5974k5q8ah
28 Jan 21
Other Events
4:05pm
8-K
1cvr178
6 Jan 21
Entry into a Material Definitive Agreement
5:16pm
8-K
xnp rtciv7
29 Dec 20
Entry into a Material Definitive Agreement
4:00pm
8-K
eg4e1z2keuc0m
10 Dec 20
Departure of Directors or Certain Officers
5:21pm
8-K
5ms55tsxa5q qzah8
10 Nov 20
Entry into a Material Definitive Agreement
5:16pm
8-K
stpaqrwb87bn
10 Nov 20
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:05pm
8-K
ofvbyz9ehh03 svtn
16 Sep 20
Other Events
4:07pm
8-K
0tnipk6ccj9pf0
1 Sep 20
Departure of Directors or Certain Officers
4:12pm
8-K
m81hvyiz d50rnc5lkw
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
8-K
rmfy27biusu3f
7 Aug 20
Assignment and Novation Agreement
4:08pm
8-K
1q5 scbbwpp1ndwdm
6 Jul 20
Our mission is to create a world without infectious disease
6:32am